DTQ: Console, Heart-Lung Machine, Cardiopulmonary Bypass: FDA Product Code 510(k) Clearances, Predicate Lineage, and Recall History (1977 to 2023)
U.S. FDA CDRH three-letter product classification DTQ in Cardiovascular (21 CFR 870.4220) reconciled across 1977 to 2023.
Review 52 FDA 510(k) clearances, 17 recalled K-numbers, and 267 cumulative 1976 to 2026 CDRH recall notices for DTQ: Console, Heart-Lung Machine, Cardiopulmonary Bypass on Predicate Ledger.
| Regulatory Metric | Verified Value |
|---|---|
| Entity Classification | FDA 3-Letter Product Code (DTQ, Class 2) |
| Clinical Advisory Specialty | Cardiovascular (Panel CV) |
| Cleared FDA 510(k) Submissions (1976 to 2026) | 52 clearances (6 California, 11.5%) |
| Cleared 510(k)s Linked to a Recall Notice | 17 K-numbers (32.69% of cleared cohort) |
| Cumulative Historical Recall Notices (1976 to 2026) | 267 notices (3 Class I, 261 Class II, 3 Class III) |
| Currently Open vs Historical Recall Status | Cumulative 1976 to 2026 FDA archive total (267 notices); verify live open vs terminated status per notice in dossier |
| Implantable and Life-Sustaining Clearances | 0 implantable (0.0%) and 52 life-sustaining |
| Median FDA 510(k) Review Duration | 73 days (90th percentile: 291 days) |
Cumulative recall counts span 1976 to 2026 across U.S. FDA CDRH and openFDA public archives and combine closed historical notices with any currently open field actions. Browse all device cohorts, 20 clinical specialties, Shared 510(k) Predicate Lineage Stage, or reconciliation methodology.
Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.